Astrazeneca Pharma India receives Import and Market permission for Osimertinib Tablet – Business Standard


Business Standard

Astrazeneca Pharma India receives Import and Market permission for Osimertinib Tablet
Business Standard
Astrazeneca Pharma India has received Import and Market permission in Form 45 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Osimertinib Tablet 40 mg and 80 mg (TagrissoTM) indicated as first-line ...
AstraZeneca receives nod to import, market cancer drugIndia.com News

all 12 news articles »